Ryvu Therapeutics SA
WSE:RVU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Maritima de Inversiones SA
SGO:MARINSA
|
CL |
|
A
|
Acroud AB
STO:ACROUD
|
SE |
|
N
|
New Century Group Hong Kong Ltd
HKEX:234
|
HK |
|
E
|
Enel Americas SA
SGO:ENELAM
|
CL |
|
Lang & Schwarz AG
XETRA:LUS1
|
DE |
|
Zhejiang Yingfeng Technology Co Ltd
SSE:605055
|
CN |
|
Yintai Gold Co Ltd
SZSE:000975
|
CN |
Ryvu Therapeutics SA
Other
Ryvu Therapeutics SA
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Other
zł1k
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-63%
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Other
zł411.3k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Selvita SA
WSE:SLV
|
Other
-zł10.8m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-85%
|
CAGR 10-Years
N/A
|
|
Ryvu Therapeutics SA
Glance View
Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 186 full-time employees. The company went IPO on 2011-07-14. The firm is active in the pharmaceutical and biotechnology fields. The company operates through two business segments. The Innovative segment develops new drugs mainly for oncology and central nervous system diseases. The Services segment is engaged in the research and development activities, such as introducing substances on the market, client service and reducing the risk. The Company’s portfolio encompasses projects, including kinesis inhibitors platform, the platform of the metabolism for the cancer and epigenetic, among others. Ryvu Therapeutics SA is active in the domestic market and internationally, such as in the United States. The company operates through unit Ardigen SA and SORS Holdings Ltd.
See Also
What is Ryvu Therapeutics SA's Other?
Other
1k
PLN
Based on the financial report for Dec 31, 2025, Ryvu Therapeutics SA's Other amounts to 1k PLN.
What is Ryvu Therapeutics SA's Other growth rate?
Other CAGR 10Y
-63%
The average annual Other growth rates for Ryvu Therapeutics SA have been -74% over the past three years , and -63% over the past ten years .
